Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/en/projects/184-randomized-study-with-a-run-in-feasibility-phase-to-assess-the-added-value-of-clofarabine-in-combination-with-standard-remission-induction-chemotherapy-in-patients-aged-18-65-years-with-previously-untreated-acute-myeloid-leukemia-aml-or-myelodysplasia-mds-raeb-with-ipss-grosser-gleich-15-a-multicenter-phase-iii-trial